UK Markets closed

AbbVie to Purchase Botox Maker Allergan in $63 Billion Deal

Jun.25 -- AbbVie Inc. agreed to buy Allergan Plc in a $63 billion deal that unites the rival drug makers in a bid for growth. Bloomberg Intelligence's Sam Fazeli reports on "Bloomberg Daybreak: Americas."